Amgen (AMGN) Change in Taxes (2009 - 2026)

Amgen's Change in Taxes history runs 18 years deep, the most recent figure standing at $71.0 million for Q1 2026.

• In Q1 2026, Change in Taxes fell 31.73% year-over-year to $71.0 million; the TTM figure through Mar 2026 stood at -$2.1 billion (down 85.93% YoY), while the FY2025 annual figure was -$2.1 billion, down 104.55% from the prior year.
• Change in Taxes was $71.0 million for Q1 2026 at Amgen, up from -$365.0 million in the prior quarter.
• In the past five years, Change in Taxes ranged from a high of $610.0 million in Q3 2025 to a low of -$2.4 billion in Q2 2025.
• Historically, Change in Taxes has averaged -$275.6 million across 5 years, with a median of $71.0 million in 2026.
• The sharpest annual moves came in 2022 and 2024: Change in Taxes jumped 511.54% in 2022, then slumped 5578.57% in 2024.
• A 5-year view of Change in Taxes shows it stood at -$155.0 million in 2022, then sank by 1209.03% to -$2.0 billion in 2023, then jumped by 102.61% to $53.0 million in 2024, then slumped by 788.68% to -$365.0 million in 2025, then jumped by 119.45% to $71.0 million in 2026.
• The last three Change in Taxes figures came in at $71.0 million (Q1 2026), -$365.0 million (Q4 2025), and $610.0 million (Q3 2025), per Business Quant data.